Abstract:The gene kcnma1 encodes the α-subunit of high-conductance calcium- and voltage-dependent K+ (BK) potassium channel. With the development of generation gene sequencing technology, many KCNMA1 mutants have been identified and are more closely related to generalized epilepsy and paroxysmal dyskinesia. Here, we performed a genetic screen of 26 patients with febrile seizures and identified a novel mutation of KCNMA1 (E155Q). Electrophysiological characterization of different KCNMA1 mutants in HEK 293T cells, the previously-reported R458T and E884K variants (not yet determined), as well as the newly-found E155Q variant, revealed that the current density amplitude of all the above variants was significantly smaller than that of the wild-type (WT) channel. All the above variants caused a positive shift of the I-V curve and played a role through the loss-of-function (LOF) mechanism. Moreover, the β4 subunit slowed down the activation of the E155Q mutant. Then, we used kcnma1 knockout (BK KO) mice as the overall animal model of LOF mutants. It was found that BK KO mice had spontaneous epilepsy, motor impairment, autophagic dysfunction, abnormal electroencephalogram (EEG) signals, as well as possible anxiety and cognitive impairment. In addition, we performed transcriptomic analysis on the hippocampus and cortex of BK KO and WT mice. We identified many differentially expressed genes (DEGs). Eight dysregulated genes [i.e., (Gfap and Grm3 associated with astrocyte activation) (Alpl and Nlrp10 associated with neuroinflammation) (Efna5 and Reln associated with epilepsy) (Cdkn1a and Nr4a1 associated with autophagy)] were validated by RT-PCR, which showed a high concordance with transcriptomic analysis. Calcium imaging results suggested that BK might regulate the autophagy pathway from TRPML1. In conclusion, our study indicated that newly-found point E155Q resulted in a novel loss-of-function variant and the dysregulation of gene expression, especially astrocyte activation, neuroinflammation and autophagy, might be the molecular mechanism of BK-LOF meditated epilepsy.

Calcium-sensitive Potassium Channelopathy in Human Epilepsy and Paroxysmal Movement Disorder

De Novo BK Channel Mutation Causes Epilepsy by Regulating Voltage-Dependent, but Not Calcium-Dependent, Activation

A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca2+ sensitivity.

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

The Large Conductance Calcium- and Voltage-activated Potassium Channel (BK) and Epilepsy

Molecular Mechanisms of Epileptic Encephalopathy Caused by KCNMA1 Loss-of-Function Mutations

Both Gain- and Loss-of-function Variants of KCNA1 Are Associated with Paroxysmal Kinesigenic Dyskinesia.

Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia

Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesignic dyskinesia

The R900S Mutation in CACNA1S Associated with Hypokalemic Periodic Paralysis

Abstract 13049: Electrophysiological Mechanism of Potassium Channel KCNQ1 p.V162M Mutation Induced Atrial Tachycardia and Epilepsy

Familial Paroxysmal Kinesigenic Dyskinesia is Associated with Mutations in the KCNA1 Gene

CRL4ACRBN E3 Ubiquitin Ligase Restricts BK Channel Activity and Prevents Epileptogenesis

Heterozygous KCNJ10 Variants Affecting Kir4.1 Channel Cause Paroxysmal Kinesigenic Dyskinesia

A structurally precise mechanism links an epilepsy-associated KCNC2 potassium channel mutation to interneuron dysfunction

The Epilepsy of Infancy With Migrating Focal Seizures: Identification of de novo Mutations of the KCNT2 Gene That Exert Inhibitory Effects on the Corresponding Heteromeric KNa1.1/KNa1.2 Potassium Channel

Potassium channels and epilepsy

Voltage-Gated Channels As Causative Agents for Epilepsies

Voltage-gated potassium channels and genetic epilepsy

CONSTITUTIVE OPENING OF THE Kv7.2 PORE ACTIVATION GATE CAUSES KCNQ2-DEVELOPMENTAL ENCEPHALOPATHY